AUROPHARMA

Aurobindo Pharma is one of India's largest pharmaceutical companies with a strong presence in generics, APIs, injectables, biosimilars and exports across 150+ countries. The company is among the largest generic drug suppliers in the US market and continues to expand its product pipeline and manufacturing capabilities. Positives ✅ Strong US Business US remains the key revenue driver. New product launches and improving injectables business are supporting growth. ✅ Backward Integration Advantage Significant API manufacturing capability helps protect margins during raw material volatility. ✅ Growth Opportunities Biosimilars, specialty products and GLP-1 related opportunities can become future growth engines. ✅ Strong Manufacturing Base More than 29 manufacturing facilities with a large global footprint. Risks ⚠️ USFDA observations or regulatory issues can impact earnings. ⚠️ Heavy dependence on export markets, especially the US. ⚠️ Pricing pressure in generic medicines remains an industry-wide challenge. Technical View Long-term trend remains positive. Stock has been trading near its 52-week highs, indicating strong institutional interest. Immediate support: Previous swing lows and 200-DMA zone. Major resistance: Recent all-time/high zone breakout levels.